FVIII-Derived Peptides
Closed Solicitation Posted
- Solicitation number
- FDA-SOL-1225809
- Agency
- FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Place of performance
- Silver Spring MD 20993 USA
Notice details come from SAM.gov. Updated .
Notice text
The U. S. Food and Drug Administration, Center for Biologics Evaluation and Research (CBER), Office of Division of Plasma Protein Therapeutics’ (DPPT) / Hemostasis Branch (HB) require services to determine a reliable and comprehensive identification of the FVIII-derived peptides to determine if there are differences between wild-type and codon optimized proteins in the way they are processed by antigen presenting cells.
Attachments
| File | Type | Posted |
|---|---|---|
| FDA-SOL-1225809.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity